Overview

Carlsmed is a medical technology company based in Carlsbad, California, founded in 2018 and publicly traded under the ticker CARL. It has between 100 and 200 employees and reported revenue in the range of $50.5 million. The company makes the aprevo platform, which pairs AI-driven surgical planning software with 3D-printed, patient-specific spinal implants for adult spinal deformity. It serves the medical industry, including spine surgeons and hospitals. In October 2026 it launched the aprevo Lumbar Bi-lateral Posterior System.

At a glance

What Carlsmed makes

The company holds ISO 13485 certification and its aprevo platform is described by the company as the first FDA-cleared system designed specifically for adult spinal deformity.

Certifications

Carlsmed is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

• ISO 13485 — builtin.com

Latest developments

• 2026-10-14 — Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System | Wed, 10/14/2026 - 09:00 (carlsmed.com)

• 2026-10-01 — Carlsmed Appoints Tony Jarc as Chief Product and AI Officer | Thu, 10/01/2026 - 09:00 (carlsmed.com)

• 2026-09-28 — Carlsmed Appoints Richard Heppenstall as Chief Financial Officer | Mon, 09/28/2026 - 08:30 (carlsmed.com)

• 2026-08-05 — Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance | Wed, 08/05/2026 - 16:01 (carlsmed.com)

• 2026-08-03 — Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures | Mon, 08/03/2026 - 08:00 (carlsmed.com)

• 2026-05-05 — Carlsmed® Reports First Quarter 2026 Financial Results | Tue, 05/05/2026 - 16:01 (carlsmed.com)

Company details

Carlsmed added Tony Jarc as Chief Product and AI Officer on October 1, 2026 and Richard Heppenstall as Chief Financial Officer on September 28, 2026. Carlsmed was founded in 2018, has an estimated 100-200 employees, and is headquartered in Carlsbad, California. On the LightSource stability read it is rated "Established & active": 8 years in operation (founded 2018). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.

Frequently asked questions

What does Carlsmed make?

Carlsmed is a medical technology company based in Carlsbad, California, founded in 2018 and publicly traded under the ticker CARL. It has between 100 and 200 employees and reported revenue in the range of $50.5 million. The company makes the aprevo platform, which pairs AI-driven surgical planning software with 3D-printed, patient-specific spinal implants for adult spinal deformity. It serves the medical industry, including spine surgeons and hospitals. In October 2026 it launched the aprevo Lumbar Bi-lateral Posterior System.

Where is Carlsmed headquartered?

Carlsmed is headquartered in Carlsbad, California (1800 Aston Avenue, Carlsbad, California, 92008).

When was Carlsmed founded?

Carlsmed was founded in 2018.

How big is Carlsmed?

Carlsmed has an estimated 100-200 employees, with revenue in the 50.5M range.

Is Carlsmed publicly traded?

Publicly traded (NASDAQ: CARL). Public financial figures are drawn from its filings.

What certifications does Carlsmed hold?

Carlsmed lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.

Related suppliers

Explore other suppliers in the LightSource directory:

• 10xEngineers

• 1X

• 365 Retail Markets

• 3Com

• 3PAR

Last verified Nov 2026. Is this your company? Request a correction.